Related Experiment Video

Updated: Jun 20, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

Selecting the optimal antithrombotic regimen for patients with acute coronary syndromes undergoing percutaneous

Shailja V Parikh1, Ellen C Keeley

  • 1Department of Internal Medicine, Division of Cardiology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.

Vascular Health and Risk Management
|August 27, 2009
PubMed

Insights

Choosing the best antithrombotic regimen for acute coronary syndromes after percutaneous coronary intervention is complex. This review offers guidance on anticoagulant and antiplatelet therapy selection based on risk-benefit analysis.

Area of Science:

  • Cardiology
  • Pharmacology
  • Interventional Cardiology

Background:

  • Numerous anticoagulant and antiplatelet agents exist.
  • Selecting optimal antithrombotic therapy for acute coronary syndromes (ACS) post-percutaneous coronary intervention (PCI) is challenging.
  • Risk-benefit assessment is crucial for tailoring treatment.

Purpose of the Study:

  • To review mechanisms of action for common antithrombotic drugs.
  • To summarize randomized trial data for ACS patients undergoing PCI.
  • To provide a decision-making algorithm for antithrombotic regimen selection.

Main Methods:

  • Literature review of antithrombotic mechanisms.
  • Analysis of randomized controlled trials in ACS.
  • Development of a clinical algorithm integrating trial data and risk assessment.

Main Results:

  • Common antithrombotic agents have diverse mechanisms.
  • Evidence from trials informs optimal regimen selection for specific patient profiles.
  • A proposed algorithm aids in choosing antithrombotic therapy.

Conclusions:

  • Optimal antithrombotic regimens are patient-specific.
  • A risk-benefit approach combined with clinical data supports personalized therapy selection.
  • The provided algorithm facilitates informed decision-making in ACS patients undergoing PCI.

Keywords:
anticoagulantantiplateletpercutaneous coronary intervention

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...